US equities
|
MU
$978.58
▲+5.36%
META
$610.42
▼-1.58%
NVDA
$215.02
▼-1.34%
SPCX
$145.39
▼-2.15%
TSLA
$402.80
▼-1.14%
SNDK
$1,391.06
▲+6.61%
GOOGL
$323.76
▲+0.99%
ORCL
$146.19
▲+11.99%
MU
$978.58
▲+5.36%
META
$610.42
▼-1.58%
NVDA
$215.02
▼-1.34%
SPCX
$145.39
▼-2.15%
TSLA
$402.80
▼-1.14%
SNDK
$1,391.06
▲+6.61%
GOOGL
$323.76
▲+0.99%
ORCL
$146.19
▲+11.99%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Astellas Pharma ADR
(OP:
ALPMY
)
15.85
-0.09 (-0.56%)
Delayed Quote
Updated: 3:26 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Astellas Pharma ADR
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
September 01, 2023
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
Via
MarketBeat
Topics
Economy
